Literature DB >> 8040286

Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts.

K Koike1, K Moriya, H Yotsuyanagi, S Iino, K Kurokawa.   

Abstract

The HBx gene of hepatitis B virus has been shown to induce hepatic tumors in transgenic mice and is implicated in hepatocarcinogenesis in human hepatitis B virus infection. To further characterize the role of HBx gene in carcinogenesis, we established mouse fibroblast cell lines in which the expression of HBx gene could be controlled by glucocorticoid hormone and examined the effect of HBx gene expression on cell growth in vitro. Along with the expression of HBx gene, most cells in the G0/G1 phase moved into the S phase in 24 h, and the cell cycle progressed further toward 48 h. Induction of DNA synthesis was also demonstrated by bromo-deoxyuridine labeling analysis. These results indicate that HBx gene has a function to trigger the synthesis of cellular DNA and suggest that HBx gene may play a role in hepatocarcinogenesis in human infection by driving deregulated cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8040286      PMCID: PMC296280          DOI: 10.1172/JCI117343

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  Chromosomal translocation and inverted duplication associated with integrated hepatitis B virus in hepatocellular carcinomas.

Authors:  T Tokino; S Fukushige; T Nakamura; T Nagaya; T Murotsu; K Shiga; N Aoki; K Matsubara
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

2.  Characterization of hepatitis B virus X gene: in vitro translation of mRNA from COS-1 cells transfected with the X gene.

Authors:  K Koike; T Akatsuka; T Miyamura
Journal:  Virology       Date:  1988-03       Impact factor: 3.616

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication.

Authors:  R Colgrove; G Simon; D Ganem
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

5.  Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors.

Authors:  E Seto; P J Mitchell; T S Yen
Journal:  Nature       Date:  1990-03-01       Impact factor: 49.962

6.  Transgenic mouse model for human gastric carcinoma.

Authors:  K Koike; S H Hinrichs; K J Isselbacher; G Jay
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

7.  Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein.

Authors:  E Seto; T S Yen; B M Peterlin; J H Ou
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

8.  A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state.

Authors:  M Wollersheim; U Debelka; P H Hofschneider
Journal:  Oncogene       Date:  1988-11       Impact factor: 9.867

9.  Deletion in chromosome 11p associated with a hepatitis B integration site in hepatocellular carcinoma.

Authors:  C E Rogler; M Sherman; C Y Su; D A Shafritz; J Summers; T B Shows; A Henderson; M Kew
Journal:  Science       Date:  1985-10-18       Impact factor: 47.728

10.  The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells.

Authors:  Y Shirakata; M Kawada; Y Fujiki; H Sano; M Oda; K Yaginuma; M Kobayashi; K Koike
Journal:  Jpn J Cancer Res       Date:  1989-07
View more
  35 in total

1.  Different regions of hepatitis B virus X protein are required for enhancement of bZip-mediated transactivation versus transrepression.

Authors:  S Barnabas; O M Andrisani
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions.

Authors:  C R Madden; M J Finegold; B L Slagle
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

3.  Microinjection technique used to study functional interaction between p53 and hepatitis B virus X gene in apoptosis.

Authors:  X W Wang
Journal:  Mol Biotechnol       Date:  2001-06       Impact factor: 2.695

4.  The hepatitis B virus X gene induces p53-mediated programmed cell death.

Authors:  P Chirillo; S Pagano; G Natoli; P L Puri; V L Burgio; C Balsano; M Levrero
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

5.  Transfection and expression of hepatitis B virus x gene and its effect on apoptosis in HL-7702 cells.

Authors:  Hong-Ying Chen; Nan-Hong Tang; Xiu-Jin Li; Sheng-Jun Zhang; Zhi-Xin Chen; Xiao-Zhong Wang
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

6.  Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras.

Authors:  N P Klein; R J Schneider
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

7.  Premature cell cycle entry induced by hepatitis B virus regulatory HBx protein during compensatory liver regeneration.

Authors:  Amanda J Hodgson; Victor V Keasler; Betty L Slagle
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

8.  Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls.

Authors:  J Benn; R J Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

Review 9.  Inhibition of apoptosis by oncogenic hepatitis B virus X protein: Implications for the treatment of hepatocellular carcinoma.

Authors:  Chuck C K Chao
Journal:  World J Hepatol       Date:  2016-09-08

10.  The hepatitis B virus X protein modulates hepatocyte proliferation pathways to stimulate viral replication.

Authors:  Tricia L Gearhart; Michael J Bouchard
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.